Latest It Distribution News

Cash Converters International Limited reports a robust 41% increase in statutory net profit for FY2025, driven by a strategic transformation that includes exiting payday lending, expanding luxury retail, and growing its franchise footprint in Australia and the UK.

Wisr Limited has returned to profitability in FY25, driven by a doubling of loan originations and improved margins, setting the stage for ambitious growth in FY26.

EBOS Group Limited reported a 7% drop in revenue and a 21% fall in net profit for FY2025, reflecting ongoing cost pressures and restructuring impacts. The company declared a final dividend, signaling cautious optimism despite the earnings setback.

EBOS Group Limited reported solid FY25 results with 12% revenue growth and strategic acquisitions, setting sights on continued expansion and operational efficiency in FY26.

EBOS Group Limited reported a steady FY25 with 12% revenue growth and EBITDA in line with guidance, driven by strong healthcare and animal care segments. The company signals confidence with maintained dividends and a positive FY26 outlook.

EBOS Group Limited has reported a 7% decline in revenue and a 21% drop in net profit for FY2025, yet it maintains its final dividend at 61.5 NZ cents per share. The results reflect ongoing cost pressures and restructuring expenses amid a challenging market environment.

Audeara Limited reported a 19% revenue increase to $3.79 million for FY25, driven by strong Australian wholesale growth and expanding international partnerships. Despite a net loss of $1.79 million, the company’s AUA Technology division and new licensing deals position it for future profitability.

BHP Group Limited has updated its dividend announcement, confirming a fully franked USD 0.60 per share dividend for the half-year ending June 2025 and providing the South African Rand exchange rate ahead of payment.

MA Credit Income Trust has reported a $9.7 million profit and successfully raised $49.7 million through a wholesale placement, delivering a net return of 2.95% since its ASX listing in March 2025.

Cleo Diagnostics reported a $4 million loss for FY2025 while making significant strides toward FDA approval of its novel ovarian cancer blood test. The company is progressing clinical trials and scaling manufacturing in preparation for market entry.

Eildon Capital Group reported a $5.7 million net loss in FY25, weighed down by $8 million in one-off charges, while simplifying its portfolio and entering a new joint venture in North Queensland.

Eildon Capital Group reported a net loss of $5.7 million for FY2025, weighed down by significant one-off impairments, while pivoting to focused real estate investments with a new $20.8 million joint venture in Queensland.